OPTIMIZE CEFEPIME DOSING IN CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS VENOVENOUS HEMOFILTRATION

被引：0
|
作者：
Lin, Hsin [1 ]
Boidin, Clement [2 ]
Evans, Danielle
Lopez, Natasha [3 ]
Healy, Daniel [4 ]
Serpico, Elena [3 ]
Goutelle, Sylvain [5 ]
Roberts, Jason [6 ]
机构：
[1] Taipei Med Univ Hosp, Taipei, MA, Taiwan
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Cincinnati, Cincinnati, OH USA
[5] Hosp Pierre Garraud, Lyon, France
[6] Univ Queensland, Brisbane, Qld, Australia
来源：
CRITICAL CARE MEDICINE | 2019年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
610
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration
    Ververs, TFT
    van Dijk, A
    Vinks, SATMM
    Blankestijn, PJ
    Savelkoul, TJF
    Meulenbelt, J
    Boereboom, FTJ
    CRITICAL CARE MEDICINE, 2000, 28 (10) : 3412 - 3416
  • [2] Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment
    Jiang, Sai-Ping
    Xu, Yan-Yan
    Ping-Yang
    Wu, Wei-Fang
    Zhang, Xing-Guo
    Lu, Xiao-Yang
    Xiao, Yong-Hong
    Liang, Wei-Feng
    Chen, Jian
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (10) : 930 - 935
  • [3] Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration
    Bilgrami, I.
    Roberts, J. A.
    Wallis, S. C.
    Thomas, J.
    Davis, J.
    Fowler, S.
    Goldrick, P. B.
    Lipman, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (07) : 2974 - 2978
  • [4] Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration
    Chunlu Gao
    Jing Tong
    Kaijiang Yu
    Zhidan Sun
    Ran An
    Zhimin Du
    European Journal of Clinical Pharmacology, 2016, 72 : 823 - 830
  • [5] Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration
    Gao, Chunlu
    Tong, Jing
    Yu, Kaijiang
    Sun, Zhidan
    An, Ran
    Du, Zhimin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (07) : 823 - 830
  • [6] Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration
    Franquiz, Miguel J.
    Kalaria, Shamir N.
    Armahizer, Michael J.
    Gopalakrishnan, Mathangi
    McCarthy, Paul J.
    Badjatia, Neeraj
    PHARMACOTHERAPY, 2018, 38 (02): : E17 - E21
  • [7] VANCOMYCIN IN CRITICALLY ILL PATIENTS RECEIVING ACCELERATED VENOVENOUS HEMOFILTRATION
    Medar, Nihad
    Ware, Lydia
    Degrado, Jeremy
    Lupi, Kenneth
    Pearson, Jeffrey
    Kubiak, David
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [8] Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients
    Bugge, JF
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2001, 45 (08) : 929 - 934
  • [9] Influence of continuous venovenous hemofiltration on the hemodynamics of critically ill patients
    SanchezIzquierdo, JA
    Alted, E
    Lozano, MJ
    Vela, JLP
    Caballero, R
    Cobo, P
    NEFROLOGIA, 1996, 16 (04): : 336 - 341
  • [10] Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients
    Guenter, SG
    Iven, H
    Boos, C
    Bruch, HP
    Muhl, E
    PHARMACOTHERAPY, 2002, 22 (02): : 175 - 183
12345